The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000032:analysis* / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis; D004798:Enzymes / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D006899:Mixed Function Oxygenases; D009206:Myocardium / Q000032:analysis; D009526:Nialamide / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology*
D002395:Catecholamines; D004798:Enzymes; D008781:Methyltyrosines; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006899:Mixed Function Oxygenases; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine